Jonathan Zung
Corporate Officer/Principal presso CURIS, INC.
Patrimonio netto: - $ in data 31/03/2024
Profilo
Jonathan B.
Zung is currently the Chief Development Officer at Curis, Inc. He previously held positions as Chairman at Clinical Data Interchange Standards Consortium, Inc., Group President-Clinical Development at Labcorp Drug Development, Inc., VP & Head-Global Clinical Sciences & Operations at UCB SA, and President-Sponsor & CRO Programs at WIRB- Copernicus Group, Inc. He also served as the Chief Development Officer at Evelo Biosciences, Inc. Additionally, he holds a doctorate degree from Emory University and an undergraduate degree from Florida Institute of Technology, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
EVELO BIOSCIENCES, INC.
-.--% | 27/11/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Posizioni attive di Jonathan Zung
| Società | Posizione | Inizio |
|---|---|---|
| CURIS, INC. | Corporate Officer/Principal | 01/05/2023 |
Precedenti posizioni note di Jonathan Zung
| Società | Posizione | Fine |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Corporate Officer/Principal | 03/03/2023 |
Clinical Data Interchange Standards Consortium, Inc.
 Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Chairman | 01/01/2021 |
WIRB- Copernicus Group, Inc.
 WIRB- Copernicus Group, Inc. Miscellaneous Commercial ServicesCommercial Services WIRB- Copernicus Group, Inc. engages in the provision solutions for clinical research. The firm offers study planning and site optimization, patient engagement, scientific and regulatory, market insights, and ethical and biosafety review services. The company was founded in 2012 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 01/12/2020 |
| COVANCE INC. | Corporate Officer/Principal | 01/04/2018 |
| UCB | Corporate Officer/Principal | 01/04/2016 |
Formazione di Jonathan Zung
| Emory University | Doctorate Degree |
| Florida Institute of Technology, Inc. | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CURIS, INC. | Health Technology |
| UCB | Health Technology |
| EVELO BIOSCIENCES, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
Clinical Data Interchange Standards Consortium, Inc.
Clinical Data Interchange Standards Consortium, Inc. Miscellaneous Commercial ServicesCommercial Services Clinical Data Interchange Standards Consortium, Inc. is a non-profit organization that creates clarity in clinical research by developing and advancing data standards of the highest quality. CDISC standards are required by the United States Food and Drug Administration (FDA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA), recommended by the China National Medical Products Administration (NMPA), and adopted by the world's leading research organizations. These standards enable the accessibility, interoperability, and reusability of data, maximizing the value of data for more efficient and meaningful research that has invaluable impact on health. CDISC actively collaborates with Europe's Innovative Medicines Initiative and is strategically positioned as a standards governance body that supports and maintains standards not only for clinical research but also for public health. The American company was founded by Rebecca Daniels Kush and David A. Evans has been the CEO of the company since 2021. | Commercial Services |
WIRB- Copernicus Group, Inc.
WIRB- Copernicus Group, Inc. Miscellaneous Commercial ServicesCommercial Services WIRB- Copernicus Group, Inc. engages in the provision solutions for clinical research. The firm offers study planning and site optimization, patient engagement, scientific and regulatory, market insights, and ethical and biosafety review services. The company was founded in 2012 and is headquartered in Princeton, NJ. | Commercial Services |
Clintrax Global, Inc.
 Clintrax Global, Inc. Engineering & ConstructionIndustrial Services Clintrax Global, Inc. specializes in global clinical trial contract negotiation and investigator payments. Its services include site payments, resource placement, contract negotiations, and budget development services. The company was founded by Brandon Evans and Matthew Amsden and is headquartered in Raleigh, NC. | Industrial Services |
- Borsa valori
- Insiders
- Jonathan Zung
